Gara Jalqabaatti › Kansara Selii Merkel
Qorannoo klinikaalii Kansara Selii Merkel Ameerikaa Keessatti hirmaatuu
Qorannoo 24 Kansara Selii Merkel f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 6
- Boston, MAQorannoo 5
- San Antonio, TXQorannoo 4
- New York City, NYQorannoo 4
- Tampa, FLQorannoo 4
- Nashville, TNQorannoo 3
- Los Angeles, CAQorannoo 3
- Pittsburgh, PAQorannoo 3
- St. Louis, MOQorannoo 3
- Arlington, VAQorannoo 3
- Queens, NYQorannoo 3
- Washington, DCQorannoo 3
- Miami, FLQorannoo 3
- Jacksonville, FLQorannoo 3
- Seattle, WAQorannoo 3
Naannoon
- CaliforniaQorannoo 5
- FloridaQorannoo 11
- MarylandQorannoo 3
- MassachusettsQorannoo 5
- MichiganQorannoo 5
- MissouriQorannoo 3
- New JerseyQorannoo 3
- New YorkQorannoo 4
- North CarolinaQorannoo 3
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 3
- TexasQorannoo 8
- VirginiaQorannoo 3
- WashingtonQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07285044Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05583708Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
1 Day – 100 Years · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02471352Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06814496Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07006727A Study of CRD3874-SI in People With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06021626Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05267626Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02479698Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT05896839Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05269381A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07115043A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05859074A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07749586Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT05100095Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT04975152MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05076760Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06947928EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06223659Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT05496036TIL Therapy in cSCC and MCC
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT07288073IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Onk-2025 · NCT06940440A Beta-only IL-2 ImmunoTherapY Study
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.